ARDS: Challenges in patient care and frontiers in research

European Respiratory Review

Volumn 27, Issue 147, 2018, Pages

  Bos, Lieuwe D ^a   Martin Loeches, Ignacio ^b   Schultz, Marcus J ^a,c  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b ST JAMES S HOSPITAL   (Ireland)

^c MAHIDOL UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; BIOLOGICAL MARKER; GLUCOCORTICOID; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; NEUROMUSCULAR BLOCKING AGENT; SALBUTAMOL; STEROID; SURFACTANT; RESPIRATORY TRACT AGENT;

ADULT RESPIRATORY DISTRESS SYNDROME; ARTERIAL OXYGEN TENSION; ARTICLE; ARTIFICIAL VENTILATION; CLINICAL PRACTICE; DISEASE SEVERITY; ENDOTRACHEAL INTUBATION; EXTRACORPOREAL OXYGENATION; HUMAN; INTERACTIVE VENTILATORY SUPPORT; MAJOR CLINICAL STUDY; PATIENT CARE; PHENOTYPE; POSITIVE END EXPIRATORY PRESSURE; PRONE POSITION; TIDAL VOLUME; TRACHEOTOMY; CLINICAL DECISION MAKING; DRUG EFFECT; FORECASTING; HEALTH SERVICES RESEARCH; LUNG; MASS COMMUNICATION; PATHOPHYSIOLOGY; PATIENT SELECTION; PULMONOLOGY; RESPIRATORY CARE; TREATMENT OUTCOME; TRENDS;

CLINICAL DECISION-MAKING; DIFFUSION OF INNOVATION; FORECASTING; HEALTH SERVICES RESEARCH; HUMANS; LUNG; PATIENT SELECTION; PULMONARY MEDICINE; RESPIRATION, ARTIFICIAL; RESPIRATORY DISTRESS SYNDROME, ADULT; RESPIRATORY SYSTEM AGENTS; RESPIRATORY THERAPY; TREATMENT OUTCOME;

EID: 85041298716     PISSN: 09059180     EISSN: 16000617     Source Type: Journal    
DOI: 10.1183/16000617.0107-2017     Document Type: Article

References (71)

1. Rhodes A, Evans LE, Alhazzani W, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Intensive Care Med 2017; 43: 304-377.
2. Chiumello D, Brochard L, Marini JJ, et al. Respiratory support in patients with acute respiratory distress syndrome: an expert opinion. Crit Care 2017; 21: 240.
3. Martin-Loeches I, Levy MM, Artigas A. Management of severe sepsis: advances, challenges, and current status. Drug Des Devel Ther 2015; 9: 2079-2088.
4. Martin-Loeches I, Perner A. Focus on infection and sepsis in intensive care patients. Intensive Care Med 2016; 42: 491-493.
5. Delclaux C, L’Her E, Alberti C, et al. Treatment of acute hypoxemic nonhypercapnic respiratory insufficiency with continuous positive airway pressure delivered by a face mask: a randomized controlled trial. JAMA 2000; 284: 2352-2360.
6. Brambilla AM, Aliberti S, Prina E, et al. Helmet CPAP vs. oxygen therapy in severe hypoxemic respiratory failure due to pneumonia. Intensive Care Med 2014; 40: 942-949.
7. Patel BK, Wolfe KS, Pohlman AS, et al. Effect of noninvasive ventilation delivered by helmet vs face mask on the rate of endotracheal intubation in patients with acute respiratory distress syndrome: a randomized clinical trial. JAMA 2016; 315: 2435-2441.
8. Frat J-P, Thille AW, Mercat A, et al. High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure. N Engl J Med 2015; 372: 2185-2196.
9. Agarwal R, Aggarwal AN, Gupta D. Role of noninvasive ventilation in acute lung injury/acute respiratory distress syndrome: a proportion meta-analysis. Respir Care 2010; 55: 1653-1660.
10. Berg KM, Lang GR, Salciccioli JD, et al. The rapid shallow breathing index as a predictor of failure of noninvasive ventilation for patients with acute respiratory failure. Respir Care 2012; 57: 1548-1554.
11. Carteaux G, Millán-Guilarte T, De Prost N, et al. Failure of noninvasive ventilation for de novo acute hypoxemic respiratory failure: role of tidal volume. Crit Care Med 2016; 44: 282-290.
12. Rittayamai N, Katsios CM, Beloncle F, et al. Pressure-controlled vs volume-controlled ventilation in acute respiratory failure: a physiology-based narrative and systematic review. Chest 2015; 148: 340-355.
13. Young D, Harrison DA, Cuthbertson BH, et al. Effect of early vs late tracheostomy placement on survival in patients receiving mechanical ventilation: the TracMan randomized trial. JAMA 2013; 309: 2121-2129.
14. Hosokawa K, Nishimura M, Egi M, et al. Timing of tracheotomy in ICU patients: a systematic review of randomized controlled trials. Crit Care 2015; 19: 424.
15. ARDS-Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 2000; 342: 1301-1308.
16. Wolthuis EK, Korevaar JC, Spronk P, et al. Feedback and education improve physician compliance in use of lung-protective mechanical ventilation. Intensive Care Med 2005; 31: 540-546.
17. Terragni PP, Rosboch G, Tealdi A, et al. Tidal hyperinflation during low tidal volume ventilation in acute respiratory distress syndrome. Am J Respir Crit Care Med 2007; 175: 160-166.
18. Retamal J, Libuy J, Jiménez M, et al. Preliminary study of ventilation with 4. ml/kg tidal volume in acute respiratory distress syndrome: feasibility and effects on cyclic recruitment -derecruitment and hyperinflation. Crit Care 2013; 17: R16.
19. Putensen C, Theuerkauf N, Zinserling J, et al. Meta-analysis: ventilation strategies and outcomes of the acute respiratory distress syndrome and acute lung injury. Ann Intern Med 2009; 151: 566-576.
20. Amato MBP, Meade MO, Slutsky AS, et al. Driving pressure and survival in the acute respiratory distress syndrome. N Engl J Med 2015; 372: 747-755.
21. Brower RG, Lanken PN, MacIntyre N, et al. Higher versus lower positive end-expiratory pressures in patients with the acute respiratory distress syndrome. N Engl J Med 2004; 351: 327-336.
22. Meade MO, Cook DJ, Guyatt GH, et al. Ventilation strategy using low tidal volumes, recruitment maneuvers, and high positive end-expiratory pressure for acute lung injury and acute respiratory distress syndrome. JAMA 2008; 299: 637-645.
23. Mercat A, Richard J-C, Vielle B, et al. Positive end-expiratory pressure setting in adults with acute lung injury and acute respiratory distress syndrome: a randomized controlled trial. JAMA 2008; 299: 646-655.
24. Briel M, Meade M, Mercat A, et al. Higher vs lower positive end-expiratory pressure in patients with acute lung injury and acute respiratory distress syndrome: systematic review and meta-analysis. JAMA 2010; 303: 865-873.
25. Goligher EC, Kavanagh BP, Rubenfeld GD, et al. Oxygenation response to positive end-expiratory pressure predicts mortality in acute respiratory distress syndrome. A secondary analysis of the LOVS and ExPress trials. Am J Respir Crit Care Med 2014; 190: 70-76.
26. Kacmarek RM, Villar J, Sulemanji D, et al. Open lung approach for the acute respiratory distress syndrome: a pilot, randomized controlled trial. Crit Care Med 2016; 44: 32-42.
27. Talmor D, Sarge T, Malhotra A, et al. Mechanical ventilation guided by esophageal pressure in acute lung injury. N Engl J Med 2008; 359: 2095-2104.
28. Sud S, Friedrich JO, Taccone P, et al. Prone ventilation reduces mortality in patients with acute respiratory failure and severe hypoxemia: systematic review and meta-analysis. Intensive Care Med 2010; 36: 585-599.
29. Guérin C, Reignier J, Richard J-C, et al. Prone positioning in severe acute respiratory distress syndrome. N Engl J Med 2013; 368: 2159-2168.
30. Beitler JR, Sands SA, Loring SH, et al. Quantifying unintended exposure to high tidal volumes from breath stacking dyssynchrony in ARDS: the BREATHE criteria. Intensive Care Med 2016; 42: 1427-1436.
31. Guervilly C, Bisbal M, Forel JM, et al. Effects of neuromuscular blockers on transpulmonary pressures in moderate to severe acute respiratory distress syndrome. Intensive Care Med 2017; 43: 408-418.
32. Papazian L, Forel JM, Gacouin A, et al. Neuromuscular blockers in early acute respiratory distress syndrome. N Engl J Med 2010; 363: 1107-1116.
33. Neto AS, Pereira M, Espósito DC, et al. Neuromuscular blocking agents in patients with acute respiratory distress syndrome: a summary of the current evidence from three randomized controlled trials. Ann Intensive Care 2012; 2: 33.
34. Ventetuolo CE, Muratore CS. Extracorporeal life support in critically ill adults. Am J Respir Crit Care Med 2014; 190: 497-508.
35. Peek GJ, Mugford M, Tiruvoipati R, et al. Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial. Lancet 2009; 374: 1351-1363.
36. Marhong JD, Munshi L, Detsky M, et al. Mechanical ventilation during extracorporeal life support (ECLS): a systematic review. Intensive Care Med 2015; 41: 994-1003.
37. Fanelli V, Ranieri M V, Mancebo J, et al. Feasibility and safety of low-flow extracorporeal carbon dioxide removal to facilitate ultra-protective ventilation in patients with moderate acute respiratory distress syndrome. Crit Care 2016; 20: 36.
38. Thompson B, Chambers R, Liu K. Acute respiratory distress syndrome. N Engl J Med 2017; 377: 562-572.
39. González-López A, Astudillo A, García-Prieto E, et al. Inflammation and matrix remodeling during repair of ventilator-induced lung injury. Am J Physiol Lung Cell Mol Physiol 2011; 301: L500-L509.
40. Lorente JA, Ballén-Barragán A, Herrero R, et al. Acute respiratory distress syndrome: does histology matter? Crit Care 2015; 19: 337.
41. Boyle AJ, McNamee JJ, McAuley DF. Biological therapies in the acute respiratory distress syndrome. Expert Opin Biol Ther 2014; 14: 969-981.
42. Cain DW, Cidlowski JA. Immune regulation by glucocorticoids. Nat Rev Immunol 2017; 17: 233-247.
43. Meduri GU, Bridges L, Shih M-C, et al. Prolonged glucocorticoid treatment is associated with improved ARDS outcomes: analysis of individual patients’ data from four randomized trials and trial-level meta-analysis of the updated literature. Intensive Care Med 2016; 42: 829-840.
44. Smith FG, Perkins GD, Gates S, et al. Effect of intravenous β-2. agonist treatment on clinical outcomes in acute respiratory distress syndrome (BALTI-2): a multicentre, randomised controlled trial. Lancet 2012; 379: 229-235.
45. Davidson WJ, Dorscheid D, Spragg R, et al. Exogenous pulmonary surfactant for the treatment of adult patients with acute respiratory distress syndrome: results of a meta-analysis. Crit Care 2006; 10: R41.
46. Zhang Y, Ding S, Li C, et al. Effects of N-acetylcysteine treatment in acute respiratory distress syndrome: a meta-analysis. Exp Ther Med 2017; 14: 2863-2868.
47. Grommes J, Soehnlein O. Contribution of neutrophils to acute lung injury. Mol Med 2011; 17: 293-307.
48. Iwata K, Doi A, Ohji G, et al. Effect of neutrophil elastase inhibitor (sivelestat sodium) in the treatment of acute lung injury (ALI) and acute respiratory distress syndrome (ARDS): a systematic review and meta-analysis. Intern Med 2010; 49: 2423-2432.
49. Paine R, Standiford TJ, Dechert RE, et al. A randomized trial of recombinant human granulocyte-macrophage colony stimulating factor for patients with acute lung injury. Crit Care Med 2012; 40: 90-97.
50. Thomas DW, Burns J, Audette J, et al. Clinical Development Success Rates 2006-2015. BIO Industry Analysis. https://www.bio.org/sites/default/files/Clinical%20Development%20Success%20Rates%202006-2015%20-%20BIO,% 20Biomedtracker,%20Amplion%202016.pdf Biotechnology Innovation Organization (BIO), 2016.
51. Gattinoni L, Giomarelli P. Acquiring knowledge in intensive care: merits and pitfalls of randomized controlled trials. Intensive Care Med 2015; 41: 1460-1464.
52. Matute-Bello G, Frevert CW, Martin TR. Animal models of acute lung injury. Am J Physiol Lung Cell Mol Physiol 2008; 295: L379-L399.
53. Matute-Bello G, Downey G, Moore BB, et al. An official American Thoracic Society workshop report: features and measurements of experimental acute lung injury in animals. Am J Respir Cell Mol Biol 2011; 44: 725-738.
54. Bellani G, Laffey JG, Pham T, et al. Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50. countries. JAMA 2016; 315: 788-800.
55. Schouten LRA, Helmerhorst HJF, Wagenaar GTM, et al. Age-dependent changes in the pulmonary renin-angiotensin system are associated with severity of lung injury in a model of acute lung injury in rats. Crit Care Med 2016; 44: e1226-e1235.
56. Schouten LRA, Schultz MJ, van Kaam AH, et al. Association between maturation and aging and pulmonary responses in animal models of lung injury: a systematic review. Anesthesiology 2015; 123: 389-408.
57. Agrawal A, Zhuo H, Brady S, et al. Pathogenetic and predictive value of biomarkers in patients with ALI and lower severity of illness: results from two clinical trials. Am J Physiol Lung Cell Mol Physiol 2012; 303: L634-L639.
58. Prescott AHC, Calfee CS, Taylor B, et al. Towards smarter lumping and smarter splitting: rethinking strategies for sepsis and acute respiratory distress syndrome clinical trial design. Am J Respir Crit Care Med 2016; 194: 147-155.
59. Auffray C, Adcock IM, Chung KF, et al. An integrative systems biology approach to understanding pulmonary diseases. Chest 2010; 137: 1410-1416.
60. Shankar-Hari M, McAuley DF. Divide and conquer: identifying acute respiratory distress syndrome subphenotypes. Thorax 2017; 72: 867-869.
61. Hu SL, He HL, Pan C, et al. The effect of prone positioning on mortality in patients with acute respiratory distress syndrome: a meta-analysis of randomized controlled trials. Crit Care 2014; 18: R109.
62. Guérin C. Prone ventilation in acute respiratory distress syndrome. Eur Respir Rev 2014; 23: 249-257.
63. Gattinoni L, Taccone P, Carlesso E, et al. Prone position in acute respiratory distress syndrome. Rationale, indications, and limits. Am J Respir Crit Care Med 2013; 188: 1286-1293.
64. Park SY, Kim HJ, Yoo KH, et al. The efficacy and safety of prone positioning in adults patients with acute respiratory distress syndrome: a meta-analysis of randomized controlled trials. J Thorac Dis 2015; 7: 356-367.
65. Calfee CS, Delucchi K, Parsons PE, et al. Subphenotypes in acute respiratory distress syndrome: latent class analysis of data from two randomised controlled trials. Lancet Respir Med 2014; 2: 611-620.
66. Famous KR, Delucchi K, Ware LB, et al. Acute respiratory distress syndrome subphenotypes respond differently to randomized fluid management strategy. Am J Respir Crit Care Med 2017; 195: 331-338.
67. Bos LD, Schouten LR, van Vught LA, et al. Identification and validation of distinct biological phenotypes in patients with acute respiratory distress syndrome by cluster analysis. Thorax 2017; 72: 876-883.
68. Scicluna BP, van Vught LA, Zwinderman AH, et al. Classification of patients with sepsis according to blood genomic endotype: a prospective cohort study. Lancet Respir Med 2017; 5: 816-826.
69. Silva S, Ait Aissa D, Cocquet P, et al. Combined thoracic ultrasound assessment during a successful weaning trial predicts postextubation distress. Anesthesiology 2017; 127: 666-674.
70. Davenport EE, Burnham KL, Radhakrishnan J, et al. Genomic landscape of the individual host response and outcomes in sepsis: a prospective cohort study. Lancet Respir Med 2016; 4: 259-271.
71. The National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network. Comparison of two fluid-management strategies in acute lung injury. N Engl J Med 2006; 354: 2564-2575.